Trace how a poorly perfused kidney can sustain systemic hypertension, interpret RAAS drug effects, and distinguish renal artery disease that needs intervention.
A patient has a blood pressure of 188/102 mmHg, yet one kidney is signaling inadequate perfusion. There is no contradiction. A renal artery narrowing can separate the pressure measured at the arm from the pressure reaching the kidney. The important question is whether that local deficit is driving a treatable clinical syndrome, not simply whether imaging shows a narrow artery.
Locate the signal before naming the hormone
Renin is produced by granular juxtaglomerular cells, specialized cells in the arteriolar wall near the entrance to the glomerulus. They have smooth-muscle lineage and secretory features. The juxtaglomerular apparatus also includes the macula densa, specialized tubular epithelium at the end of the thick ascending limb where the tubule returns to the vascular pole, and extraglomerular mesangial cells.
The macula densa is a sensor, not the principal renin-secreting cell population. Sustained demand can recruit additional renin-expressing cells along the arteriolar lineage. A teaching description of increased granular cells illustrates adaptation; kidney biopsy is not the routine diagnostic test for renal artery stenosis. [1][2]
Three inputs encourage renin release. Reduced renal perfusion pressure reduces vascular stretch. Reduced sodium chloride uptake at the macula densa through NKCC2 promotes local signals including prostaglandin E2. Sympathetic beta-1 stimulation acts on granular cells. These pathways overlap during hemorrhage, volume depletion, heart failure with poor effective arterial filling, or renal artery stenosis. The kidney does not directly compare its pressure with a cuff reading. [2][3]
Keep filtration, perfusion, and salt delivery separate. A low macula densa sodium chloride signal can reflect tubular transport as well as reduced filtration. A loop diuretic inhibits NKCC2 at the sensor as well as in the thick ascending limb and can stimulate renin. NSAIDs inhibit prostaglandin synthesis, interfering with both renin-related signaling and support of renal perfusion in vulnerable states. A measured renin value therefore depends on medicines, sodium intake, posture, disease duration, and physiology. Renal artery stenosis does not guarantee a high renin value on every blood draw.
Try it here · Checkpoint 1 of 3
Make your prediction before reading the choices. A first attempt is just a starting point.
Case 2
Show answer and explanations for case 2
A. Reduced arteriolar stretch, lower macula densa NaCl uptake, and beta-1 stimulation (Best answer)
These converging signals fit the reduction in effective circulation following blood loss.
B. Increased angiotensin II feedback at the granular cell (Why this does not fit)
Angiotensin II provides negative feedback on renin, whereas reduced perfusion and sympathetic activity explain the initial renin increase after blood loss.
C. Increased arteriolar stretch with suppressed sympathetic activity (Why this does not fit)
Those changes would generally oppose the renin response expected during hypoperfusion.
D. High macula densa NaCl uptake with angiotensin II feedback (Why this does not fit)
High salt signaling and angiotensin feedback tend to restrain renin rather than explain its increase.
Takeaway: Renin integrates local perfusion, tubular salt delivery, and sympathetic input.
Follow the signal to vessels, tubules, and the adrenal cortex
The circulating RAAS pathway with its major destinations
Liver supplies angiotensinogen
This circulating substrate is not angiotensin I.
Renin cleaves angiotensinogen to angiotensin I
Granular cells supply the enzyme. Formation of circulating angiotensin I is not confined to the liver.
ACE converts angiotensin I to angiotensin II
ACE is present on vascular endothelium, prominently in the pulmonary circulation but also elsewhere. It also participates in bradykinin breakdown.
Angiotensin II acts through AT1 receptors
Vascular constriction supports pressure. Renal tubular sodium absorption increases. The adrenal zona glomerulosa secretes aldosterone. Thirst and vasopressin release support water retention.
Aldosterone acts in the distal nephron
Principal cells increase sodium absorption through ENaC and favor potassium secretion through separate potassium channels. Intercalated-cell acid secretion also increases.
Angiotensin II promotes proximal sodium and bicarbonate reabsorption, including through NHE3-related transport. Its vascular and tubular actions cooperate to defend effective circulation. Aldosterone increases expression and activity of sodium transport machinery rather than exchanging sodium for potassium through a single shared channel. Potassium exits through channels such as ROMK and BK. Alpha-intercalated cells handle hydrogen secretion; they should not be drawn as identical to principal cells. High potassium can itself stimulate aldosterone, independently of renin. [4][5]
Vasopressin, also called ADH, is synthesized in the hypothalamus and transported to the posterior pituitary for storage and release. [16] Its V2-mediated collecting duct action increases water permeability. Aldosterone primarily supports sodium retention; vasopressin controls the final water adjustment. This distinction explains why heart failure can cause edema and dilutional hyponatremia at the same time. More total body sodium does not guarantee a higher serum sodium concentration.
Restoration of circulation and angiotensin II feedback tend to suppress renin. Long-standing activation can also contribute to maladaptive vascular and cardiac remodeling. ACE inhibitors and ARBs therefore have benefits in selected albuminuric CKD and heart failure patients even though a short-term hemodynamic fall in filtration can accompany treatment. Drug effects must be interpreted against the indication and the kidney's dependence on angiotensin II. [6][7]
Understand why creatinine can rise when pressure falls
Blood flow through one glomerulus, with two different drug-sensitive sites
Renal artery supplies incoming blood
A severe upstream stenosis lowers pressure delivered to the kidney.
Afferent arteriole enters the glomerulus
Local prostaglandins help preserve inflow during low-perfusion states. NSAIDs can reduce this support.
Glomerular capillaries filter plasma
Filtration depends on the pressure balance, plasma oncotic pressure, and filtration properties, not inflow alone.
Efferent arteriole exits the glomerulus
Angiotensin II preferentially increases efferent resistance within a physiological range. ACE inhibitors and ARBs reduce this effect and can lower glomerular capillary pressure.
Constriction after a filter can help preserve the pressure inside it when incoming pressure is limited. This is the useful efferent-arteriole explanation of angiotensin II. It is not a universal promise of preserved GFR. Severe vasoconstriction, reduced renal plasma flow, and other changes can eventually reduce filtration. Likewise, an ACE inhibitor does not close the efferent arteriole. It reduces angiotensin-dependent constriction. [5][8]
In unilateral disease with a functioning contralateral kidney, total GFR may remain adequate while filtration on the stenotic side falls. The other kidney can also excrete sodium in response to systemic hypertension, a process called pressure natriuresis. A normal overall creatinine therefore does not prove that both kidneys are equally protected. When both renal arteries are severely affected, or a single functioning kidney is supplied through a stenosis, there is less reserve.
RAAS blockade can then cause a substantial creatinine rise. Such patients require specialist assessment and close monitoring; a simplistic rule that every anatomical stenosis permanently forbids every ACE inhibitor is too broad. [8][9]
KDIGO recommends reassessing blood pressure, creatinine, and potassium within two to four weeks after starting or increasing an ACE inhibitor or ARB, with timing adapted to risk. A creatinine rise greater than thirty percent within four weeks calls for investigation. Assess volume depletion, hypotension, NSAIDs, other kidney injury, and renovascular disease rather than treating the percentage as a diagnostic test for bilateral stenosis. Smaller stable rises may be compatible with continuing indicated therapy. Hyperkalemia also needs active management, and uncontrolled hyperkalemia or symptomatic hypotension may require dose reduction or discontinuation. [6]
Try it here · Checkpoint 2 of 3
Make your prediction before reading the choices. A first attempt is just a starting point.
Case 5
Show answer and explanations for case 5
A. Urinary obstruction raises intratubular pressure and reduces filtration (Why this does not fit)
Obstruction can reduce filtration, but the timing after ACE inhibition in severe bilateral stenosis favors loss of efferent pressure support.
B. Efferent arteriolar resistance increases after ACE inhibition (Why this does not fit)
ACE inhibition reduces angiotensin-dependent efferent constriction; it does not increase resistance at that site.
C. Reduced efferent resistance lowers glomerular capillary pressure (Best answer)
The underperfused kidneys may rely on angiotensin-dependent efferent constriction to maintain filtration pressure.
D. Direct acute proximal tubular necrosis is the primary drug action (Why this does not fit)
ACE inhibitors can cause a hemodynamic filtration decrease in angiotensin-dependent kidneys without a primary necrotic tubular action.
Takeaway: A fall in filtration can result from reduced pressure support without direct tubular poisoning.
Distinguish a vascular finding from renovascular hypertension
Atherosclerotic renal artery disease usually affects the ostium and proximal artery in a patient with a broader vascular risk burden. Fibromuscular dysplasia is nonatherosclerotic and noninflammatory, often involving the middle or distal renal artery. Multifocal disease can produce alternating stenoses and dilatations, while focal FMD may lack a beaded appearance. FMD is more frequent in women, but sex and age are probability modifiers rather than diagnostic requirements. Essential hypertension can also begin in young adulthood. [8][10]
Atherosclerotic pattern Ostial or proximal plaque, additional vascular disease, often a medical-treatment-first strategy when clinically stable.
FMD pattern Mid-distal focal narrowing or multifocal beading, no plaque-based explanation, possible benefit from angioplasty when the lesion is causing clinically important hypertension.
Consider renovascular disease with abrupt worsening of blood pressure control, objectively confirmed resistant hypertension, asymmetric kidney size, unexplained rapid kidney function decline, recurrent flash pulmonary edema, or a marked renal response to RAAS blockade. An abdominal bruit supports suspicion but its absence does not exclude disease. Before labeling hypertension resistant, assess measurement technique, out-of-office readings, adherence, adequate doses, an appropriate diuretic, and interfering drugs. Primary aldosteronism and obstructive sleep apnea are important competing explanations. No short list based solely on age replaces this assessment.
Choose imaging to answer a management question. Duplex ultrasound assesses arterial velocities and kidney characteristics without contrast but depends on technical quality and acoustic access. CTA depicts vascular anatomy using iodinated contrast and radiation. Contrast-enhanced MRA uses gadolinium-based contrast, so calling every MRA contrast-free is incorrect; noncontrast techniques also exist. Kidney function, local expertise, suspected distal disease, and the need for intervention affect selection.
Catheter angiography is invasive and may be appropriate when noninvasive studies leave consequential uncertainty or an intervention is planned. A captopril renogram is a historical functional test with limitations, especially in advanced CKD and bilateral disease, not an automatic modern first-line study. [8][9]
Captopril renography compares renal tracer handling before and after ACE inhibition. A fall in angiotensin-dependent filtration can alter uptake or transit. It measures a functional response rather than directly showing a narrowed artery, and a positive test alone does not establish benefit from revascularization. [17]
Select treatment by the clinical syndrome and the evidence
Most stable atherosclerotic disease is treated with blood pressure control, lipid management, smoking cessation, and antiplatelet therapy when indicated by the vascular context. ACE inhibitors or ARBs can be useful with renal and potassium surveillance. CORAL and ASTRAL did not establish a benefit from routine renal artery intervention added to medical therapy for their overall enrolled populations. Finding a stenosis on a scan is therefore not enough to promise that a stent will preserve kidney function or cure hypertension. [11][12]
The trials do not settle every high-risk presentation. Recurrent flash pulmonary edema, rapidly declining kidney function associated with severe occlusive disease, or truly refractory hypertension can justify multidisciplinary assessment for revascularization. Evidence supporting revascularization in these selected high-risk syndromes is largely observational and expert consensus, not proof of benefit from the overall neutral randomized trials. Flash edema is particularly associated with bilateral disease or stenosis supplying the functioning renal mass, but it is not anatomically restricted to two stenotic arteries. Stabilize the acute cardiopulmonary problem first while evaluating the renovascular contribution. [8]
For hemodynamically important FMD-related hypertension, catheter assessment and balloon angioplasty may be appropriate. Routine stenting is generally not the initial FMD approach unless needed for a complication or selected lesion circumstances. Blood pressure cure is variable and less likely after prolonged hypertension; medical follow-up remains necessary even after a technically successful procedure. Do not turn a demographic description into an automatic intervention order. [8][10]
Use renin and aldosterone together
High aldosterone with suppressed renin suggests primary aldosteronism. Renin-driven aldosterone excess, as may occur with renovascular hypertension, tends to increase both. Hypertension with low renin and low aldosterone suggests a different mechanism, such as Liddle syndrome or apparent mineralocorticoid excess from licorice exposure. [15] Hypokalemia supports the diagnosis when present; its absence does not exclude primary aldosteronism.
Low potassium can suppress aldosterone and cause a misleading screen. The 2025 Endocrine Society guideline conditionally suggests screening people with hypertension using aldosterone and renin, interpreted with potassium, medications, sampling conditions, resources, and local expertise. An adrenal image alone does not establish hormone excess or lateralization. [13]
ACE inhibitors reduce angiotensin II formation and bradykinin degradation, accounting for cough and angioedema risk. ARBs block AT1 receptors and generally cause less cough, but are not free of angioedema risk. Both require pregnancy avoidance and monitoring for potassium retention and hemodynamic kidney injury. Beta-1 blockade can reduce renin release but does not guarantee unchanged GFR.
Avoid routine dual RAAS blockade. Sacubitril/valsartan already contains an ARB and must not overlap an ACE inhibitor; allow at least thirty-six hours between the two. Aliskiren with an ACE inhibitor or ARB is contraindicated in diabetes. Mineralocorticoid antagonists act farther downstream and add potassium risk, even when the combination has a valid heart failure indication. [5][6][7][14]
Sacubitril is converted to a neprilysin inhibitor, reducing breakdown of peptides including natriuretic peptides. Valsartan simultaneously blocks AT1 signaling. This explains the combination of enhanced natriuretic peptide activity and reduced angiotensin effects; it does not remove the need for the ACE inhibitor washout or potassium, kidney and blood-pressure monitoring. [14]
Try it here · Checkpoint 3 of 3
Make your prediction before reading the choices. A first attempt is just a starting point.
Case 17
Show answer and explanations for case 17
A. Primary open renal artery bypass (Why this does not fit)
Surgery has selected roles, but balloon angioplasty is generally preferred for a suitable uncomplicated FMD lesion.
B. Primary renal endarterectomy (Why this does not fit)
This plaque-directed procedure is not the usual initial approach to a suitable nonatherosclerotic FMD lesion.
C. Primary balloon-expandable stent placement (Why this does not fit)
Routine primary stenting is generally unnecessary for FMD and is reserved for selected circumstances.
D. Balloon angioplasty with stenting reserved for selected circumstances or complications (Best answer)
FMD differs from ostial atherosclerotic plaque, and routine primary stenting is generally unnecessary.
Takeaway: FMD intervention requires selection and does not guarantee cure.
A. Review volume and drugs promptly; stop naproxen and consider holding lisinopril temporarily (Best answer)
The 50-percent creatinine rise warrants prompt assessment and correction of reversible factors. Volume depletion and NSAID exposure are competing explanations; assess other AKI causes and renovascular disease if indicated.
B. Arrange renal artery stenting because this creatinine rise establishes the diagnosis of bilateral stenosis (Why this does not fit)
The numerical threshold is not an anatomical diagnosis, particularly with diarrhea and NSAID use.
C. Continue both lisinopril and naproxen because this creatinine rise falls within the expected range (Why this does not fit)
A 50-percent rise is greater than the usual threshold and requires prompt review.
D. Increase the lisinopril dose to preserve glomerular capillary pressure and support filtration (Why this does not fit)
ACE inhibition reduces angiotensin-dependent efferent resistance; escalation does not correct the stated hemodynamic risks.
Takeaway: A threshold for action is not a diagnosis.
The label requires at least 36 hours between ACE inhibitor and sacubitril/valsartan treatment because simultaneous ACE and neprilysin inhibition increases angioedema risk.
B. Twenty-four hours (Why this does not fit)
A full day is still shorter than the label-required interval.
C. Twelve hours (Why this does not fit)
This interval is shorter than the required 36-hour washout.
D. No interval if potassium and creatinine are acceptable (Why this does not fit)
Laboratory suitability does not remove the overlap-related angioedema risk.
Takeaway: The ACE-to-ARNI transition has a specific mandatory interval.
A. Low effective arterial filling drives sodium retention; vasopressin drives disproportionate water retention (Best answer)
Total extracellular fluid excess can coexist with an arterial perfusion signal that activates RAAS and antidiuresis.
B. Isolated dietary sodium deficiency accounts for the hormonal response, without a change in effective circulation (Why this does not fit)
The patient has congestive heart failure and edema, so low effective arterial filling with disproportionate water retention is more coherent than isolated dietary deficiency.
C. Primary aldosteronism drives sodium retention, with accompanying water retention independent of vasopressin (Why this does not fit)
Renin is increased in this low-effective-circulation state; primary aldosteronism would ordinarily suppress renin and does not explain the same pattern.
D. Effective arterial filling remains adequate despite the edema, leading to suppression of renin release (Why this does not fit)
The increased renin and advanced heart failure indicate reduced effective filling despite interstitial volume excess.
Takeaway: Distinguish total body fluid from the effective circulation sensed by the kidney.
